A. Masago

A single nucleotide insertion in the 5'-untranslated region of hepatitis C virus leads to enhanced cap-independent translation.

O. Yamada, Jing Zhang, Takayoshi Ito, 1999, Virology.

Persistent and Stable Gene Expression by a Cytoplasmic RNA Replicon Based on a Noncytopathic Variant Sendai Virus*

M. Morishita, T. Imamura, K. Takayama, 2007, Journal of Biological Chemistry.

Gene transfer vectors based on Sendai virus.

H. Inokuchi, T. Mayumi, T. Hayakawa, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Circulating tumor cells as a prognostic factor in patients with small cell lung cancer

A. Masago, K. Katono, N. Masuda, 2014, Oncology letters.

TRF1 is a critical trans-acting factor required for de novo telomere formation in human cells.

T. Hayakawa, A. Eguchi, M. Nakanishi, 2000, Human molecular genetics.

BALB/c 3T3 cells co-expressing FGF-2 and soluble FGF receptor acquire tumorigenicity.

M. Seno, H. Yamada, K. Igarashi, 1998, Cytokine.

A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients

Y. Tamaki, S. Noguchi, A. Masago, 2011, Breast Cancer Research and Treatment.

Identification and Characterization of Cell Lines with a Defect in a Post-adsorption Stage of Sendai Virus-mediated Membrane Fusion*

T. Hayakawa, A. Eguchi, Jianhong Hu, 2000, The Journal of Biological Chemistry.

Gene delivery systems using the Sendai virus.

T. Mayumi, H. Mizuguchi, T. Hayakawa, 1999, Molecular membrane biology.